Clinical Trial Update: Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use" [Phase 4]

View source ↗

Summary

Phase 4 trial comparing continuous celecoxib use versus usual or intermittent use in osteoarthritis shows completed results with posted outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Osteoarthritis of the Knee

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip | Phase 4 | Status: COMPLETED | Results posted: 2009-05-19